BioEclipse Therapeutics™ to Present at Virtual H.C. Wainwright 23rd Annual Global Healthcare Conference

MOUNTAIN VIEW, Calif.: MOUNTAIN VIEW, Calif., Sept. 10, 2021 /PRNewswire/ -- BioEclipse Therapeutic™, a clinical-stage immuno-oncology company focused on developing innovative therapeutics based on its patented natural killer T-cell (NKT)/oncolytic virus technology platform, announced today that Pamela Reilly Contag, Ph.D., Founder and CEO, will present at the H.C. Wainwright Annual...

Click to view original post